#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



Journal articles Case history acquired haemophilia A

Author of the article: Z. Čermáková, R. Hrdličková, Š. Blahutová, A. Ligová Source: Vnitřní lékařství | 4/2013 1. 4. 2013

Journal articles Characteristics and results of treatment of younger patients less than 60 years old with AML: analysis of real data from the Czech DATOOL-AML database

Author of the article: L. Semerád, Z. Šustková, P. Cetkovský, P. Jindra, Z. Kořístek, J. Novák, T. Szotkowski, Z. Ráčil, J. Vydra, B. Weinbergerová, P. Žák, J. Mayer Source: Transfuze a hematologie dnes | 3/2020 17. 7. 2020

News Metformin in Pregnancy and Its Safety Profile

In Finland, a comprehensive analysis of data from the national registry was conducted to assess whether exposure to metformin during intrauterine development is associated with an increased risk of long-term or short-term health problems.
Source: Modern Treatment of Diabetes 6. 6. 2022

News Oral Azacitidine After Achieving Remission in AML Improves Survival and Does Not Worsen Quality of Life

Orally administered azacitidine as maintenance therapy in patients with acute myeloid leukemia (AML) after achieving remission provides a favorable effect in terms of fatigue and improving health-related quality of life (HRQoL). This is based on the results of the QUAZAR AML-001 study, which were published in the journal Haematologica.
Source: Acute Myeloid Leukemia 10. 10. 2023

News Long-term Efficacy of Targeted Therapy for Axial Spondyloarthritis

How does etanercept fare in the long-term treatment of early axial spondyloarthritis (axSpA)? Data from over 10 years of follow-up in patients with both radiographic and non-radiographic forms of axSpA were recently published in the journal Therapeutic Advances in Musculoskeletal Disease as part of the extended clinical trial ESTHER.
Source: Arthritis 19. 4. 2022

News X-ray in Dentistry: Who Can Indicate and Who Can Perform?

X-ray is an integral and important part of dental diagnostics. However, since it is also a source of ionizing radiation, its use is subject to legislative regulations that govern it.
Source: Dental Care 4. 6. 2024

News Ocrelizumab in the Treatment of Multiple Sclerosis – 10-Year Data

Multiple sclerosis (MS) is a lifelong disease with a high risk of permanent disability. Current information on the long-term efficacy and safety of treatment is therefore absolutely essential for the optimal choice of therapeutic agent – in this case, ocrelizumab.
Source: Neurology - Multiple Sclerosis 20. 2. 2024

News Nucleic Acid Amplification Tests in the Diagnosis of Sexually Transmitted Diseases

Based on 81 scientific papers published between 2010 and 2021, experts from Johns Hopkins University in Baltimore have prepared an overview of the current epidemiology, diagnosis, and treatment of sexually transmitted diseases (STD). We summarize information on the diagnosis of gonorrhea, chlamydial infections, M. genitalium, trichomoniasis, genital infections by HSV-1/2, and HPV using nucleic acid amplification tests (NAAT), the most well-known method being PCR. NAAT shows high sensitivity and specificity in testing for these diseases.
Source: Genetics 28. 6. 2023

News Association of M2 Haplotype of the Annexin A5 Gene with Recurrent Reproductive Losses

Annexin A5 (ANXA5) is a placental anticoagulant protein that ensures adequate blood supply to the fetus during pregnancy, and its deficiency can increase the incidence of vascular thrombosis in the placenta. Current research shows that the M2 haplotype of the ANXA5 gene may be associated with recurrent reproductive losses and obstetric complications due to placental disorders.
Source: Genetics 5. 5. 2023

Journal articles Canabis in the Development and Homeostasis of the Nerve System

Author of the article: J. Blahoš Jr Source: Česká a slovenská neurologie a neurochirurgie | 5/2013 9. 9. 2013

News Maintenance Therapy of a Female Patient with AML After Intense Chemotherapy – Case Study

The following case study presents the case of a female patient with acute myeloid leukemia (AML) who experienced life-threatening complications after the second consolidation chemotherapy, rendering her incapable of undergoing further intense therapy or allogeneic HSCT. In this situation, maintenance therapy with oral azacitidine proved beneficial – this modality, due to its good tolerance, can be used as a bridge until allo-HSCT can be performed in patients in poor clinical condition.
Source: Acute Myeloid Leukemia 10. 5. 2024

Journal articles Cutaneous and Mucosal Candidoses

Author of the article: I. Kuklová Source: Česko-slovenská dermatologie | 2/2015 17. 6. 2015

News When and why to consider the diagnosis of myasthenia gravis in neurological practice, and what treatment options do we currently have?

Myasthenia gravis (MG) is a clinically heterogeneous disease characterized by fluctuating muscle weakness and fatigability that worsens after physical exertion or mental stress. Accurate diagnosis is essential because treatment can lead to permanent remission and full functional capacity of the patient.
Source: Rare Diseases in Neurology 2. 5. 2023

News Why does the heart enlarge? Myosin mutation and hypertrophic cardiomyopathy may be the culprits

The genetic basis of hypertrophic cardiomyopathy was discovered only about a quarter-century ago. Since then, researchers have gathered a wealth of knowledge about the effects of causal mutations. Today, new drugs are available that directly target the molecular basis of the disease. The following text explains how mutations in heart muscle proteins are linked to myocardial hypertrophy.
Source: Hypertrophic Cardiomyopathy (HCM) 7. 9. 2023

News A Look at Tongue and Its Care from the Perspective of Western and Traditional Chinese Medicine

The tongue is a valuable diagnostic tool used in both Traditional Chinese Medicine (TCM) and Western medicine. While the approaches to tongue care between these two medical systems differ significantly, both recognize the tongue's ability to reflect an individual's overall health. Although these approaches may seem contradictory, with proper application, they can complement each other.
Source: Dental Care 6. 9. 2023

News Hybrid Cooperating Complexes in Osteoarthritis Treatment

Intra-articular application of corticosteroids and hyaluronic acid is part of the treatment of osteoarthritis (OA) in patients for whom oral or topical treatment does not provide sufficient response. The following text addresses the lubricating and protective properties of synovial fluid and the associated choice of suitable intra-articular viscosupplementation, with an emphasis on innovative molecules with high concentrations of hyaluronic acid and low viscosity.
Source: Pain Management 21. 6. 2024

News Benefit of Oral Semaglutide for Patients with Type 2 Diabetes in the General Practitioner's Office

Oral semaglutide is a modern antidiabetic suitable within primary care for people with type 2 diabetes, primarily due to its comprehensive action that includes not only reducing blood glucose and body weight but also a number of other favorable non-glycemic effects.
Source: Modern Treatment of Diabetes with GLP-1 Analogues 22. 5. 2024

Journal articles Periodic fevers and other autoinflammatory diseases

Author of the article: Šárka Fingerhutová, Eva Jančová, Markéta Tesařová, Lenka Dvořáková, Pavla Doležalová Source: Časopis lékařů českých | 3/2018 27. 6. 2018

News Impact of Prophylaxis on Reducing the Risk of Neurological Problems Associated with Bleeding in Hemophilia A

Bleeding can also cause complications in the nervous system of hemophiliacs. The authors of the work presented below discuss the significance of prophylactic administration of factor VIII coagulation concentrates, specifically concerning neurological complications related to bleeding.
Source: Hemophilia 14. 4. 2022

Journal articles Von Willebrand disease

Author of the article: P. Smejkal, M. Matýšková, M. Penka Source: Vnitřní lékařství | 3/2008 9. 3. 2008

News Reducing Overall Mortality by Combining Three Antihypertensives into a Single Pill

Treating hypertension to recommended target blood pressure values often requires a combination of three antihypertensives. By simply combining these three substances into a single pill, it is possible to increase treatment adherence, reduce overall mortality in hypertensive patients, and lower healthcare costs within one year. This is demonstrated by a freshly published Italian real-world study.
Source: Risk factors of cardiovascular diseases 26. 6. 2024

News CASE STUDY: Rocker who can enjoy life again thanks to DM2 compensation p.o. semaglutide and better lifestyle

Diabetologist MUDr. Lucie Radovnická from Masaryk Hospital in Ústí nad Labem illustrates the case of her patient − a sympathetic rocker who enjoys life including concerts, beer, and good food − demonstrating how modern antidiabetic treatment with oral semaglutide in combination with thorough lifestyle re-education can achieve very good diabetes compensation and overall health improvement. One of the many benefits of this modality was the possibility to discontinue sulfonylurea derivative medication, which previously caused severe hypoglycemia.
Source: Modern Treatment of Diabetes with GLP-1 Analogues 18. 6. 2024

Journal articles Primary immunodeficiencies in adults

Author of the article: Jiří Litzman Source: Vnitřní lékařství | 2/2019 15. 3. 2019

News Subclinical Hypothyroidism in Pregnancy: How Great Are the Real Risks and Can They Be Effectively Reduced?

The aim of the meta-analysis by authors from the Mayo Clinic was to describe the impact of subclinical hypothyroidism on the course of pregnancy and the effect of levothyroxine replacement therapy in reducing the risk of possible complications.
Source: Thyroid Disorders 25. 4. 2023

News Options for Systemic Therapy of Advanced Stage Small Cell Lung Cancer

Small cell lung cancer (SCLC) is the most aggressive type of lung tumor. Although it responds well to chemotherapy and radiotherapy, due to the early onset of treatment resistance, the 5-year survival rate is less than 10%. After more than 30 years of very limited progress in treating advanced SCLC patients, immune checkpoint inhibitors (checkpoints) have been introduced to the market, significantly prolonging survival. What are the current recommendations for treating patients with advanced SCLC?
Source: Small Cell Lung Cancer 22. 2. 2024

1 7 8 9 10 11 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#